ticlopidine has been researched along with Necrobiosis Lipoidica Diabeticorum in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnetblanc, JM | 1 |
| Julia, A | 1 |
| Rigaud, M | 1 |
| Rhodes, EL | 1 |
2 other studies available for ticlopidine and Necrobiosis Lipoidica Diabeticorum
| Article | Year |
|---|---|
Antithrombotic agents in necrobiosis lipoidica.
Topics: Adolescent; Adult; Diabetes Complications; Female; Fibrinolytic Agents; Humans; Necrobiosis Lipoidic | 1986 |
Necrobiosis lipoidica treated with ticlopidine.
Topics: Humans; Necrobiosis Lipoidica; Ticlopidine | 1986 |